Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy

  title={Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy},
  author={Ilia Stambler},
  journal={Aging and Disease},
  pages={583 - 589}
  • I. Stambler
  • Published 1 October 2017
  • Medicine
  • Aging and Disease
It is becoming increasingly clear that in order to accomplish healthy longevity for the population, there is an urgent need for the research and development of effective therapies against degenerative aging processes underlying major aging-related diseases, including heart disease, neurodegenerative diseases, type 2 diabetes, cancer, pulmonary obstructive diseases, as well as aging-related complications and susceptibilities of infectious communicable diseases. Yet, an important incentive for… 
Editorial: Clinical Evaluation Criteria for Aging and Aging-Related Multimorbidity
The main aim of the current Research Topic was to contribute to establishing the methodological basis for developing, and regulatory adoption of, diagnostic criteria for aging and aging-related multimorbidity.
What Do We Need to Know to Treat Degenerative Aging as a Medical Condition to Extend Healthy Lifespan?
  • I. Stambler
  • Medicine, Political Science
    The Transhumanism Handbook
  • 2019
It can be confidently stated that healthy lifespan extension is one of the most important healthcare, economic and humanitarian tasks for the entire global community.
Is Aging a Disease? Biodemographers’ Point of View
There is no need to declare that aging is a disease because aging already has its individual code in ICD, R54, and this issue was publicly discussed in detail at the congress of the International Association of Gerontology and Geriatrics in June 2017.
Emerging Anti-Aging Strategies - Scientific Basis and Efficacy
Several approaches are at the forefront of becoming mainstream therapies for combating aging and postponing age-related diseases in the coming years and have shown considerable promise for improving function in aging.
Health and Aging: Unifying Concepts, Scores, Biomarkers and Pathways
This work proposes to define health as a state of an individual characterized by the core features of physiological, cognitive, physical and reproductive function, and a lack of disease, and defines healthspan pathways as molecular features of health that relate to each other by belonging to the same molecular pathway.
Are We Ill Because We Age?
As there is no common definition of what aging is, what its causes are, why it occurs, and what should be the target(s) for interventions, it is impossible to conclude that aging is a disease.
Human ageing as a dynamic, emergent and malleable process: from disease-oriented to health-oriented approaches
It is important to recognise the limitations of reductionist and disease-oriented approaches in slowing down ageing and preventing age-related diseases in the future and consider holistic and evidence-based strategies.
Establishing a Comprehensive Anti-aging Research Center: Experiences and Challenges
Introduction: Age-related diseases have become the leading causes of morbidity and mortality worldwide. Anti-aging researches both at the population and individual levels are still urgently needed.
Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
There is an urgent unmet need to develop reliable strategies to slow down and delay the ageing process to gain a greater understanding of their potential beneficial effects on brain ageing and health span in humans.


Classifying aging as a disease in the context of ICD-11
The arguments for classifying aging as a disease in the context of the upcoming World Health Organization’s 11th International Statistical Classification of Diseases and Related Health Problems (ICD-11), expected to be finalized in 2018 are explored.
The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population.
The following policies are advocated: increasing funding for research and development specifically directed to ameliorate degenerative aging processes and to extend healthy and productive lifespan for the population.
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic
Current approaches to selection of geroprotectors are reviewed and a suggested selection criteria is put forth, which will streamline discovery and analysis of new candidates, saving time and cost involved in translation to clinic.
The Demographic and Biomedical Case for Late-Life Interventions in Aging
An ambitious global initiative is advocated to translate findings into interventions for aging humans, using three complementary approaches to retard, arrest, and even reverse aging damage, extending and even restoring the period of youthful health and functionality of older people.
Medical research: Treat ageing
Post-mortems reveal that tumours, heart problems, neurodegeneration and metabolic disease are generally reduced or delayed in long-lived mice, and extending lifespan also seems to increase ‘healthspan’, the time lived without chronic age-related conditions.
Frailty in older adults: evidence for a phenotype.
This study provides a potential standardized definition for frailty in community-dwelling older adults and offers concurrent and predictive validity for the definition, and finds that there is an intermediate stage identifying those at high risk of frailty.
A Trial for the ages.
An unprecedented clinical trial is proposed in which half the subjects would get a placebo and half would get an old drug for type 2 diabetes called metformin, which has been shown to modify aging in some animal studies.
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
The Alzheimer's Prevention Initiative (API) is proposed to evaluate investigational amyloid-modifying treatments in healthy people who, based on their age and genetic background, are at the highest imminent risk of developing symptomatic AD using brain imaging, cerebrospinal fluid (CSF), and cognitive endpoints.
Substantial health and economic returns from delayed aging may warrant a new focus for medical research.
Overall, greater investment in research to delay aging appears to be a highly efficient way to forestall disease, extend healthy life, and improve public health.